Xeris Biopharma unveils CEO succession plan, John Shannon to lead company

Group 1 - The company specializes in medium and small-cap markets while also providing updates on blue-chip companies, commodities, and broader investment stories to engage private investors [1] - The company is recognized as a forward-looking and enthusiastic adopter of technology [2] - Automation and software tools, including generative AI, are utilized by the company, but all content is edited and authored by humans to ensure quality and adherence to best practices [3] Group 2 - The publisher's news team operates from key financial hubs worldwide, including London, New York, Toronto, Vancouver, Sydney, and Perth [4] - Angela Harmantas, an editor with over 15 years of experience in equity markets, particularly in junior resource stocks, leads the content production [5] - The team provides news and insights across various sectors, including biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [6]